The obesity epidemic continues to affect millions of Americans, with approximately two-thirds of the population classified as overweight or obese.[1] Individuals who are overweight or have obesity are more likely to develop type 2 diabetes (T2D), though not everyone with excess weight develops the condition.[2] For non-diabetics seeking support with weight loss, semaglutide has gained significant attention
call 999 or attend A&E for severe symptoms such as severe abdominal pain with systemic illness, severe dehydration, or altered consciousness
Journal of Functional Foods, 112, 105944
G., Holmgren, A., Arner, E
There are versions of those drugs Wegovy and Zepbound approved for people with obesity
To strike a new chord with the audience, Cinca said the pharma giant sought to create an ad campaign that is irreverent and attention-grabbing